Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
In response to: Benefit of neo...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
In response to: Benefit of neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction.
Bibliographic Details
Main Authors:
Knight, SR
,
Morris, P
Format:
Journal article
Language:
English
Published:
2008
Holdings
Description
Similar Items
Staff View
Similar Items
Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome
by: Sailaja Kesiraju, et al.
Published: (2014-01-01)
Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
by: Ngan N. Lam, MD, et al.
Published: (2021-08-01)
Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
by: Martina Koch, et al.
Published: (2009-01-01)
Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial
by: Aziza Ajlan, et al.
Published: (2021-06-01)
POS-744 CLINICAL CORRELATES AND OUTCOMES OF DUAL BASILIXIMAB AND THYMOGLOBULIN INDUCTION IN KIDNEY TRANSPLANT RECIPIENTS: A NATIONAL STUDY
by: N. Lam N, et al.
Published: (2021-04-01)